{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T20:10:50Z","timestamp":1791835850176,"version":"4.3.4"},"reference-count":44,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K09523"],"award-info":[{"award-number":["17K09523"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21K08109"],"award-info":[{"award-number":["21K08109"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009665","name":"Vehicle Racing Commemorative Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019702","name":"Tokyo Metropolitan Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.numecd.2023.12.013","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T02:21:35Z","timestamp":1702952495000},"page":"1325-1333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence and clinical characteristics of diabetic cardiomyopathy in patients with acute heart failure"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-3117","authenticated-orcid":false,"given":"Kenichi","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumasa","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2719-7424","authenticated-orcid":false,"given":"Takeshi","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1021-6238","authenticated-orcid":false,"given":"Ken","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morimasa","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2023.12.013_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/0002-9149(72)90595-4","article-title":"New type of cardiomyopathy associated with diabetic glomerulosclerosis","volume":"30","author":"Rubler","year":"1972","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.hfc.2019.02.003","article-title":"Diabetic cardiomyopathy: definition, diagnosis, and therapeutic implications","volume":"15","author":"Paolillo","year":"2019","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.numecd.2023.12.013_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Seferovi\u0107","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2023.12.013_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jacc.2004.03.037","article-title":"Insulin resistance in idiopathic dilated cardiomyopathy: a possible etiologic link","volume":"44","author":"Witteles","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib5","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2023.12.013_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00592-010-0180-x","article-title":"The diabetic cardiomyopathy","volume":"48","author":"Tarquini","year":"2011","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.numecd.2023.12.013_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12933-022-01533-5","article-title":"Impact of type 2 diabetes mellitus on left ventricular deformation in non-ischemic dilated cardiomyopathy patients assessed by cardiac magnetic resonance imaging","volume":"21","author":"Shen","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2023.12.013_bib8","article-title":"Diabetic cardiomyopathy as a clinical entity: is it a Myth?","volume":"12","author":"Zaveri","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.numecd.2023.12.013_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cardfail.2014.02.007","article-title":"The prevalence of diabetic cardiomyopathy: a population-based study in Olmsted County, Minnesota","volume":"20","author":"Dandamudi","year":"2014","journal-title":"J Card Fail"},{"key":"10.1016\/j.numecd.2023.12.013_bib10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes - global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.numecd.2023.12.013_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.numecd.2011.06.007","article-title":"Does cardiovascular phenotype explain the association between diabetes and incident heart failure? The Strong Heart Study","volume":"23","author":"de Simone","year":"2013","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2023.12.013_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.numecd.2023.12.013_bib13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib14","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ejheart.2007.09.009","article-title":"Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications","volume":"9","author":"Hartog","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2023.12.013_bib15","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.12.013_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(12)60987-8","article-title":"Diabetes and hypertension: the bad companions","volume":"380","author":"Ferrannini","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2023.12.013_bib17","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.amjcard.2017.07.054","article-title":"Effect of heart failure secondary to ischemic cardiomyopathy on body weight and blood pressure","volume":"120","author":"Matsushita","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib18","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1097\/HJH.0000000000001932","article-title":"Different prognostic associations of beta-blockers and diuretics in heart failure with preserved ejection fraction with versus without high blood pressure","volume":"37","author":"Matsushita","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2023.12.013_bib19","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1111\/jgs.16050","article-title":"Younger- vs older-old patients with heart failure with preserved ejection fraction","volume":"67","author":"Matsushita","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.numecd.2023.12.013_bib20","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2023.12.013_bib21","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.12.013_bib22","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2023.12.013_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-018-0345-3","article-title":"Japanese clinical practice guideline for diabetes 2016","volume":"9","author":"Haneda","year":"2018","journal-title":"Diabetol Int"},{"key":"10.1016\/j.numecd.2023.12.013_bib24","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2023.12.013_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amjmed.2003.09.035","article-title":"A multivariate model for predicting mortality in patients with heart failure and systolic dysfunction","volume":"116","author":"Brophy","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.numecd.2023.12.013_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCOUTCOMES.109.854877","article-title":"A validated risk score for in-hospital mortality in patients with heart failure from the American Heart Association get with the guidelines program","volume":"3","author":"Peterson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.numecd.2023.12.013_bib27","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/17446651.2023.2204941","article-title":"Treatment of type 2 diabetes patients with heart conditions","volume":"18","author":"Aktas","year":"2023","journal-title":"Expet Rev Endocrinol Metabol"},{"key":"10.1016\/j.numecd.2023.12.013_bib28","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1007\/s11845-021-02761-6","article-title":"Sodium glucose co-transporter-2 inhibitor, Empagliflozin, is associated with significant reduction in weight, body mass index, fasting glucose, and A1c levels in Type 2 diabetic patients with established coronary heart disease: the SUPER GATE study","volume":"191","author":"Bilgin","year":"2022","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.numecd.2023.12.013_bib29","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s12933-020-01109-1","article-title":"Type 2 diabetes and reduced exercise tolerance: a review of the literature through an integrated physiology approach","volume":"19","author":"Nesti","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2023.12.013_bib30","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12933-021-01314-6","article-title":"Mechanisms of reduced peak oxygen consumption in subjects with uncomplicated type 2 diabetes","volume":"20","author":"Nesti","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.numecd.2023.12.013_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1032268","article-title":"Diabetic cardiomyopathy: clinical phenotype and practice","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.numecd.2023.12.013_bib32","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/eurjhf\/hfq159","article-title":"Absence of obesity paradox in patients with chronic heart failure and diabetes mellitus: a propensity-matched study","volume":"13","author":"Adamopoulos","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2023.12.013_bib33","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/ejhf.576","article-title":"No benefit from the obesity paradox for diabetic patients with heart failure","volume":"18","author":"Zamora","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.numecd.2023.12.013_bib34","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.jacc.2014.09.067","article-title":"Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study","volume":"64","author":"Khalid","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure","volume":"1","author":"Lavie","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.numecd.2023.12.013_bib36","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(00)02690-8","article-title":"The endotoxin-lipoprotein hypothesis","volume":"356","author":"Rauchhaus","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2023.12.013_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0735-1097(00)01103-7","article-title":"Contrasting clinical properties and exercise responses in obese and lean hypertensive patients","volume":"37","author":"Weber","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molmed.2020.01.003","article-title":"Heart failure and adipose mesenchymal stem cells","volume":"26","author":"Matsushita","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.numecd.2023.12.013_bib39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2015.216","article-title":"Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy","volume":"12","author":"Jia","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.numecd.2023.12.013_bib40","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/pgmj.2007.064048","article-title":"Cardiac autonomic neuropathy in diabetes mellitus: prevalence, risk factors and utility of corrected QT interval in the ECG for its diagnosis","volume":"84","author":"Pappachan","year":"2008","journal-title":"Postgrad Med"},{"key":"10.1016\/j.numecd.2023.12.013_bib41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1006\/jmcc.2000.1123","article-title":"Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice","volume":"32","author":"Bisognano","year":"2000","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib42","doi-asserted-by":"crossref","first-page":"H1609","DOI":"10.1152\/ajpheart.00949.2007","article-title":"Metoprolol improves cardiac function and modulates cardiac metabolism in the streptozotocin-diabetic rat","volume":"294","author":"Sharma","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.numecd.2023.12.013_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejphar.2011.01.044","article-title":"\u03b2-receptor antagonist treatment prevents activation of cell death signaling in the diabetic heart independent of its metabolic actions","volume":"657","author":"Sharma","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.numecd.2023.12.013_bib44","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2016025","article-title":"Adjusting for reverse causation to estimate the effect of obesity on mortality after incident heart failure in the Atherosclerosis Risk in Communities (ARIC) study","volume":"38","author":"Shakiba","year":"2016","journal-title":"Epidemiol Health"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323005070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475323005070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:26:40Z","timestamp":1778776000000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475323005070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0939475323005070"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2023.12.013","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical characteristics of diabetic cardiomyopathy in patients with acute heart failure","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2023.12.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}